Değer20202021202220232024TTMYatırım faaliyetlerinden elde edilen nakit-7.26 M11.78 M9.7 M10.58 M8.03 M11.32 MFinansman faaliyetlerinden elde edilen nakit61.4 M7.5 M8.02 M8.84 M9.53 M—Serbest nakit akışı-30.91 M-36.5 M-22.86 M-18.02 M-19.83 M-21.69 M
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.